FlaviaCecilia Lega(Lega)HoyteMD

Allergy & Immunology • Denver, CO

Asthma & Allergic Conditions, Pediatric Asthma & Allergic Conditions

Physician

Join to view full profile

Dr. Hoyte is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hoyte's full profile

Already have an account?

Office
1400 Jackson St
Denver, CO 80206
Phone+1 303-388-4461

Fax+1 303-270-2206

Education & Training

University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 2009 - 2011
University of ChicagoResidency, Internal Medicine/Pediatrics, 2005 - 2009
New York University School of MedicineClass of 2005

Certifications & Licensure

CO State Medical License 2009 - 2025
IL State Medical License 2008 - 2009
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhi...
Joshua S Jacobs, Joseph K Han, Jason K Lee, Tanya M Laidlaw, Nicole L Martin
Advances in Therapy. 2024-11-08
Biologics in Asthma: Potential to Achieve Clinical Remission.
Orlando Rivera 2nd, Rohit Katial, Flavia C L Hoyte
Immunology and Allergy Clinics of North America. 2024-11-01
Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States.
Rohit K Katial, Flavia C L Hoyte
Annals of Allergy, Asthma & Immunology. 2024-05-01

Press Mentions

Michigan Averaging 4,205 COVID-19 Cases Per DayOctober 8th, 2021
98 Percent of ‘Highly Allergic’ People Have No Reaction After COVID-19 VaccinationSeptember 9th, 2021
Three Trials Examine Dupilumab in Moderate-to-Severe AsthmaMarch 13th, 2024
Join now to see all